<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title> CN Bio 和 Altis Biosystems 合作开发下一代人类肠道/肝脏体外模型，用于高级 ADME 研究</title><description>CN Bio 和 Altis Biosystems, Inc.（“Altis”）是体外人体器官模型的领先开发商，可优化药物开发的准确性和效率，今天宣布建立战略合作伙伴关系。</description><link/> https://www.news-medical.net/news/20240124/CN-Bio-and-Altis-Biosystems-partner-to-develop-next- Generation- human-GutLiver-in-vitro-model-for-advanced- ADME-研究.aspx<comments> https://www.news-medical.net/news/20240124/CN-Bio-and-Altis-Biosystems-partner-to-develop-next- Generation- human-GutLiver-in-vitro-model-for-advanced- ADME-studies.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=36dc70b4-97ac-4cc5-8ade-3abc066f21bb</guid><pubDate> Wed, 24 Jan 2024 05:13:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/Digital_illustration_of_liver_in_colour_background-Liya_Graphics_0fff2ea2f60c4e71b4991068b748916f-620x480.jpg" width="620"><media:description><![CDATA[CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies]]></media:description></media:content></item><item><title>新的移动应用程序被证明可以有效提高结核病药物依从性</title><description>名为游戏化实时视频观察治疗或 GRVOTS 的手机应用程序。</description><link/> https://www.news-medical.net/news/20240124/New-mobile-app-proves- effective-in-enhancing-TB-drug-adherence.aspx<comments> https://www.news-medical.net/news/20240124/New-mobile-app-proves- effective-in-enhancing-TB-drug-adherence.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=c7c6b765-51a8-4618-aada-092330f67f2e</guid><pubDate> Wed, 24 Jan 2024 05:12:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/3/Bacterial_infection_tuberculosis.red_cells_in_blue_background.AFB_3%2b_-_toeytoey_b32b49df7608432793064092cdd06996-620x480.jpg" width="620"><media:description><![CDATA[New mobile app proves effective in enhancing TB drug adherence]]></media:description></media:content></item><item><title>市售 p-tau217 免疫测定法在识别阿尔茨海默病病理生理学方面有何能力？</title><description>研究人员确定了一种新颖且市售的血浆磷酸化 tau 217 免疫测定法的效用，用于检测阿尔茨海默氏病病理学并评估三个选定队列中异常淀粉样蛋白和纵向变化的参考范围。</description><link/> https://www.news-medical.net/news/20240124/What-are-the-capability-of-a-commercially-available-p-tau217-immunoassay-to-identify-Alzheimer-disease-pathophysiology.aspx<comments> https://www.news-medical.net/news/20240124/What-are-the-capability-of-a-commercially-available-p-tau217-immunoassay-to-identify-Alzheimer-disease-pathophysiology.aspx#评论</comments><guid>https://www.news-medical.net/post.aspx?id=6311e4e4-680a-4f7c-9f4e-f73703f26c72</guid><pubDate> Wed, 24 Jan 2024 05:05:00 -0500</pubDate> <media:content expression="full" height="562" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_769908_17060903089031025.jpg" width="1000"><media:description><![CDATA[What are the capabilities of a commercially available p-tau217 immunoassay to identify Alzheimer disease pathophysiology?]]></media:description></media:content></item><item><title> Core Biogenesis 和 Nucleus Biologics 宣布战略合作，生产和分销具有成本效益和可持续的重组蛋白</title><description>为了共同努力向细胞和基因治疗市场提供更低成本、更明确的试剂和培养基，细胞和基因治疗行业定制细胞培养基解决方案的领先供应商 Nucleus Biologics, The Cell Performance Company™ 已与与植物表达重组人类蛋白领域的创新者 Core Biogenesis 签订制造、分销和合作协议。</description><link/> https://www.news-medical.net/news/20240124/Core-Biogenesis-and-Nucleus-Biologics-announce-strategic-collaboration-for-manufacturing-and-distribution-of-cost-efficient-and-sustainable-重组蛋白.aspx<comments> https://www.news-medical.net/news/20240124/Core-Biogenesis-and-Nucleus-Biologics-announce-strategic-collaboration-for-manufacturing-and-distribution-of-cost-efficient-and-sustainable-重组蛋白.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=6ff0ecd3-0c19-4b97-9300-f080c125591e</guid><pubDate> Wed, 24 Jan 2024 05:04:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/By_Gorodenkoff_571684e159074a84992c0edbe24d0030-620x480.jpg" width="620"><media:description><![CDATA[Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins]]></media:description></media:content></item><item><title>为下一次病毒大流行做好准备：APPEAL 项目</title><description>MatTek 与来自 6 个国家的 12 个合作伙伴合作，正在建立欧洲防病毒流行病防范平台 (APPEAL)，这是一项欧洲研究计划，旨在加强对未来流行病的防范。</description><link/> https://www.news-medical.net/news/20240124/Prepared-for-the-next-virus-pandemic-The-APPEAL-project.aspx<comments> https://www.news-medical.net/news/20240124/Prepared-for-the-next-virus-pandemic-The-APPEAL-project.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=14cb2dcc-5d7c-4b91-a19c-f848757cddf5</guid><pubDate> Wed, 24 Jan 2024 04:58:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Pandemic-620x480.jpg" width="620"><media:description><![CDATA[Prepared for the next virus pandemic: The APPEAL project]]></media:description></media:content></item><item><title> Plaquetec 和 Babraham 研究所合作开展冠状动脉血液表型筛查</title><description>PlaqueTec 是一家识别内型特异性生物标志物以推进冠状动脉疾病 (CAD) 精准医学的公司，总部位于 Babraham 研究园区，与 Babraham 研究所的流式细胞术设施今天宣布合作开发一种细胞表型分析方法来检测细胞人类血液中的亚群。</description><link/> https://www.news-medical.net/news/20240124/Plaquetec-and-the-Babraham-Institute-collaborate-on-phenotypic-screen-of-coronary-artery-blood.aspx<comments> https://www.news-medical.net/news/20240124/Plaquetec-and-the-Babraham-Institute-collaborate-on-phenotypic-screen-of-coronary-artery-blood.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=223f5978-104c-4484-9061-754afacb9d8b</guid><pubDate> Wed, 24 Jan 2024 04:53:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Coronary_Artery_Disease-620x480.jpg" width="620"><media:description><![CDATA[Plaquetec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood]]></media:description></media:content></item><item><title>创新的新型 Smartlid™</title><description>通过与 ProtonDx（英国伦敦）建立独家新合作伙伴关系，Alpha Laboratories（英国伊斯特利）自豪地宣布推出 SmartLid™，这是一款革命性的磁性钥匙和盖子系统，可简化核酸提取过程</description><link/>https://www.news-medical.net/news/20240124/Innovative-new-Smartlide284a2.aspx<comments> https://www.news-medical.net/news/20240124/Innovative-new-Smartlide284a2.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8cb7f1ba-fc65-4c0a-bcf4-5c07c938288b</guid><pubDate> Wed, 24 Jan 2024 04:51:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/6/Anatomical_structure_of_biological_animal_cell_with_organelles-eranicle_1d73b50575dc4546875a4a2fc7d429a6-620x480.jpg" width="620"><media:description><![CDATA[Innovative new Smartlid™]]></media:description></media:content></item><item><title>营养基因组学为乳糖不耐受护理中的定制饮食铺平了道路</title><description>目前组学工具的证据允许为乳糖不耐症 (LI) 个体制定量身定制的营养策略。</description><link/> https://www.news-medical.net/news/20240124/Nutrigenomics-paves-the-way-for-customized-diets-in-lactose-intolerance-care.aspx<comments> https://www.news-medical.net/news/20240124/Nutrigenomics-paves-the-way-for-customized-diets-in-lactose-intolerance-care.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=05ad1790-cd66-4115-bbcc-0c051f127444</guid><pubDate> Wed, 24 Jan 2024 04:47:00 -0500</pubDate> <media:content expression="full" height="1333" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_769905_17060895471255980.jpg" width="2000"><media:description><![CDATA[Nutrigenomics paves the way for customized diets in lactose intolerance care]]></media:description></media:content></item><item><title>相信咖啡因可以提高跑步表现</title><description>咖啡因摄入对跑步表现的安慰剂效应。</description><link/> https://www.news-medical.net/news/20240124/Belief-in-caffeine-ingestion-improves-running-performance.aspx<comments> https://www.news-medical.net/news/20240124/Belief-in-caffeine-ingestion-improves-running-performance.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=53e1dd72-e6f7-470b-bc83-ba3cdaf63a74</guid><pubDate> Wed, 24 Jan 2024 04:08:00 -0500</pubDate> <media:content expression="full" height="1333" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_769902_17060872347725524.jpg" width="2000"><media:description><![CDATA[Belief in caffeine improves running performance]]></media:description></media:content></item><item><title>糖尿病患者的非 COVID-19 死亡率在大流行期间增加</title><description>由马萨诸塞大学阿默斯特分校公共卫生研究人员领导的一项全球研究综述显示，在大流行期间，糖尿病患者中与 COVID-19 无关的死亡有所增加，糖尿病并发症视力丧失也有所增加，该研究审查了与大流行相关的影响对这一弱势群体造成的干扰。</description><link/> https://www.news-medical.net/news/20240123/Non-COVID-19-mortality-among-people-with-diabetes-increased-during-the-pandemic.aspx<comments> https://www.news-medical.net/news/20240123/Non-COVID-19-mortality-among-people-with-diabetes-increased-during-the-pandemic.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=79938d19-9f3c-44c2-b06c-7dff1bdeb4fe</guid><pubDate> Tue, 23 Jan 2024 22:45:59 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Insulin-620x480.jpg" width="620"><media:description><![CDATA[Non-COVID-19 mortality among people with diabetes increased during the pandemic]]></media:description></media:content></item></channel></rss>